Balaji Krishnan

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

International journal of molecular sciences

Scientific reports

University of Texas Medical Branch

University of Houston (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Medical Branch Feb 01 2015

United States

Assistant Professor :: Neurology

Education History

University of Houston Jan 01 1997 - May 09 2003

United States

PHD :: Biology and Biochemistry

Publications

Michela Marcatti, Batbayar Tumurbaatar, Michela Borghi, Jutatip Guptarak, Wen-Ru Zhang, Balaji Krishnan, Rakez Kayed, Anna Fracassi, Giulio Taglialatela
Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models. International journal of molecular sciences 25 (16) (2024)
Michela Marcatti, Batbayar Tumurbaatar, Michela Borghi, Jutatip Guptarak, Wen-Ru Zhang, Balaji Krishnan, Rakez Kayed, Anna Fracassi, Giulio Taglialatela
Inhibition of Calcineurin with FK506 Reduces Tau Levels and Attenuates Synaptic Impairment Driven by Tau Oligomers in the Hippocampus of Male Mouse Models. International journal of molecular sciences 25 (16) (2024)
Chandramouli Natarajan, Charles Cook, Karthik Ramaswamy, Balaji Krishnan
Phospholipase D1 Attenuation Therapeutics Promotes Resilience against Synaptotoxicity in 12-Month-Old 3xTg-AD Mouse Model of Progressive Neurodegeneration. International journal of molecular sciences 24 (4) (2023)
Chandramouli Natarajan, Charles Cook, Karthik Ramaswamy, Balaji Krishnan
Phospholipase D1 Attenuation Therapeutics Promotes Resilience against Synaptotoxicity in 12-Month-Old 3xTg-AD Mouse Model of Progressive Neurodegeneration. International journal of molecular sciences 24 (4) (2023)
Chandramouli Natarajan, Charles Cook, Karthik Ramaswamy, Balaji Krishnan
Phospholipase D1 Attenuation Therapeutics Promotes Resilience against Synaptotoxicity in 12-Month-Old 3xTg-AD Mouse Model of Progressive Neurodegeneration. International journal of molecular sciences 24 (4) (2023)
Chandramouli Natarajan, Charles Cook, Karthik Ramaswamy, Balaji Krishnan
Phospholipase D1 Attenuation Therapeutics Promotes Resilience against Synaptotoxicity in 12-Month-Old 3xTg-AD Mouse Model of Progressive Neurodegeneration. International journal of molecular sciences 24 (4) (2023)
Chandramouli Natarajan, Charles Cook, Karthik Ramaswamy, Balaji Krishnan
Phospholipase D1 Attenuation Therapeutics Promotes Resilience against Synaptotoxicity in 12-Month-Old 3xTg-AD Mouse Model of Progressive Neurodegeneration. International journal of molecular sciences 24 (4) (2023)
Chandramouli Natarajan, Charles Cook, Karthik Ramaswamy, Balaji Krishnan
Phospholipase D1 Attenuation Therapeutics Promotes Resilience against Synaptotoxicity in 12-Month-Old 3xTg-AD Mouse Model of Progressive Neurodegeneration. International journal of molecular sciences 24 (4) (2023)
Balaji Krishnan, Chandramouli Natarajan, Krystyn Z Bourne, Leila Alikhani, Juan Wang, Allison Sowa, Katherine Groen, Bayley Perry, Dara L Dickstein, Janet E Baulch, Charles L Limoli, Richard A Britten
Chronic Low Dose Neutron Exposure Results in Altered Neurotransmission Properties of the Hippocampus-Prefrontal Cortex Axis in Both Mice and Rats. International journal of molecular sciences 22 (7) (2021)
Krystyn Z Bourne, Chandramouli Natarajan, Carlos X Medina Perez, Batbayar Tumurbaatar, Giulio Taglialatela, Balaji Krishnan
Suppressing aberrant phospholipase D1 signaling in 3xTg Alzheimer's disease mouse model promotes synaptic resilience. Scientific reports 9 (1) (2019)
Whitney Franklin, Balaji Krishnan, Giulio Taglialatela
Chronic synaptic insulin resistance after traumatic brain injury abolishes insulin protection from amyloid beta and tau oligomer-induced synaptic dysfunction. Scientific reports 9 (1) (2019)
Michele M Comerota, Balaji Krishnan, Giulio Taglialatela
Near infrared light decreases synaptic vulnerability to amyloid beta oligomers. Scientific reports 7 (1) (2017)

Balaji Krishnan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Balaji Krishnan